Bristol-Myers Squibb Latest To License DPP-4 Patents From OSI
This article was originally published in The Pink Sheet Daily
Executive Summary
OSI "owns the patent estate" on DPP-4 inhibitors and has licensed the medical use patents to Merck, Novartis and others.